No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study. uri icon

authors

  • Desai, Rishi J
  • Horton, Daniel B
  • Kim, Seoyoung C
  • Schneeweiss, Sebastian
  • Thambisetty, Madhav
  • Mahesri, Mufaddal
  • Lee, Su Been
  • Varma, Vijay R
  • Loeffler, Tina
  • Schilcher, Irene
  • Gerhard, Tobias
  • Jodi Segal, MD, MPH
  • Ritchey, Mary E

publication date

  • January 1, 2022